No Detail Found!

Efficacy and tolerability of valsartan and hydrochlorothiazide versus valsartan and amlodipine in stage 2 hypertension

Author(s)
Abdul Karim Department of Pharmacology, Shalamar Medical & Dental College, Lahore, Pakistan
Sarwat Iqbal Department of Medicine, Shalamar Medical & Dental College, Lahore, Pakistan
Shabbir Ali Bhatti Department of Pharmacology, Shalamar Medical & Dental College, Lahore, Pakistan
Mujeeb-ur-Rehman Abid Department of Medicine, Shalamar Medical & Dental College, Lahore, Pakistan
Naveed Iqbal Department of Medicine, Shalamar Medical & Dental College, Lahore, Pakistan
Asad Ejaz Department of Medicine, Shalamar Medical & Dental College, Lahore, Pakistan
Abstract
Background: Hypertension is a growing medical and public health issue. United States and European treatment guidelines have been issued to attain smooth control of hypertension in various categories of patients. It is the need of the time to unveil the safe combination therapies in various populations. Objective: (i) To determine the efficacy of valsartan and hydrochlorothiazide versus valsartan and amlodipine (ii) To determine the safety and tolerability of both combinations. Materials & Methods: This experimental study was conducted at Shalamar Hospital Lahore. 126 patients of stage 2 hypertension were recruited from the medical outdoor of Shalamar Hospital Lahore after getting informed consent. In group A, 63 patients were given valsartan and hydrochlorothiazide. In group B, 63 patients were given valsartan and amlodipine. Blood pressure (BP) of both study groups was recorded on day zero, 2nd, 4th, and 8th weeks and the readings were entered on a Performa. The efficacy of drug combinations was accessed in both groups by recording the change in mean systolic blood pressure (MSBP) and mean diastolic blood pressure (MDBP). Safety and tolerability of the drug combinations was assessed in terms of side effects and laboratory findings. Results: In group A, there was 39±7mmzHg and 18± lmmHg decrease in MSBP and MDBP respectively from base line BP. In group B, there was 26.7±4mmHg and 14±2 mmHg decrease in MSBP and MDBP respectively from base line BP. Both combinations were safe and no significant difference in the efficacy of both combinations was observed after 8-week of treatment. Conclusion: Both combinations are effective for control of BP, but valsartan and hydrochlorothiazide combination (group A) appears to have better tolerability and greater effect in decreasing BP as compared to combination of valsartan and amlodipine (group B),although this difference is not statistically significant.
Publication Details
Page(s) 26-32
Published Journal: Journal of Shalamar Medical & Dental College (JSHMDC), Volume: 3, Issue: 1, Year: 2022

Request the full text from PASTIC

Keywords
Efficacy, Valsartan, amlodipine, hydrochlorothiazide, antihypertensive drugs
0

Citations

0

Downloads

123

Views